While Adicet Bio Inc has underperformed by -5.09%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, ACET fell by -25.16%, with highs and lows ranging from $1.63 to $0.45, whereas the simple moving average fell by -9.91% in the last 200 days.
On September 30, 2024, Guggenheim started tracking Adicet Bio Inc (NASDAQ: ACET) recommending Buy. A report published by H.C. Wainwright on September 11, 2024, Downgraded its rating to ‘Neutral’ for ACET. JP Morgan June 01, 2023d its ‘Overweight’ rating to ‘Neutral’ for ACET, as published in its report on June 01, 2023. JP Morgan’s report from September 21, 2022 suggests a price prediction of $23 for ACET shares, giving the stock a ‘Overweight’ rating. SMBC Nikko also rated the stock as ‘Outperform’.
Analysis of Adicet Bio Inc (ACET)
In order to gain a clear picture of Adicet Bio Inc’s future performance, a variety of well-rounded analysis and research techniques can be applied, with equity being the most critical. The goal here is to ensure that your current return on equity of -64.39% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 7.48, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
An average volume of 482.29K can be a very valuable indicator of volatility for ACET stock. On a monthly basis, the volatility of the stock is set at 8.02%, whereas on a weekly basis, it is put at 5.00%, with a loss of -0.98% over the past seven days. Furthermore, long-term investors anticipate a median target price of $5.60, showing growth from the present price of $0.72, which can serve as yet another indication of whether ACET is worth investing in or should be passed over.
How Do You Analyze Adicet Bio Inc Shares?
In addition to the fundamentals, you should also consider how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 20.99%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 43.09% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
